Introduction Onychomycosis (OM) is a difficult-to-treat onychopathy. The available effective drugs are limited, many a times treatment outcomes are sub-optimal. The major potential causes are prolonged treatment duration and the asymptomatic benign nature of the disease, associated with overall poor compliance and drug-associated adverse effects. T